| ||||||||||||||
|
|
|||||||||||||

Departments of *Anesthesiology and
Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin
Address correspondence and reprint requests to Quinn H. Hogan, MD, Department of Anesthesiology, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226. Address e-mail to qhogan{at}mcw.edu
The precise mechanism of isoflurane and mitochondrial adenosine triphosphate-sensitive potassium channel (mitoKATP) interaction is still unclear, although the mitoKATP is involved in isoflurane-induced preconditioning. We examined the role of various intracellular signaling systems in mitoKATP activation with isoflurane. Mitochondrial flavoprotein fluorescence (MFF) was measured to quantify mitoKATP activity in guinea pig cardiomyocytes. To confirm isoflurane-induced MFF, cells were exposed to Tyrodes solution containing either isoflurane (1.0 ± 0.1 mM) or diazoxide and then both drugs together (n = 10 each). In other studies, the following drugs were each added during isoflurane administration: adenosine or the adenosine receptor antagonist 8-(p-sulfophenyl)-theophylline (SPT); the protein kinase C (PKC) activators phorbol-12-myristate-13-acetate (PMA) and phorbol-12,13-dibutyrate (PDBu); the PKC inhibitors polymyxin B and staurosporine; the tyrosine kinase inhibitor lavendustin A; or the mitogen-activated protein kinase inhibitor SB203580 (n = 10 each). Isoflurane potentiated MFF induced by diazoxide (100 µM), and diazoxide also increased isoflurane-induced MFF. PMA (0.2 µM), PDBu (1 µM), and adenosine (100 µM) induced MFF. However, SPT (100 µM), polymyxin B (50 µM), staurosporine (200 nM), lavendustin A (0.5 µM), and SB203580 (10 µM) all failed to inhibit the effect of isoflurane. Our results show that isoflurane, adenosine, and PKC activate mitoKATP. However, our data do not support an action of isoflurane through pathways involving adenosine, PKC, tyrosine kinase, or mitogen-activated protein kinase. These results suggest that isoflurane may directly activate mitoKATP.
IMPLICATIONS: Our results show that isoflurane activates mitochondrial adenosine triphosphate-sensitive potassium (mitoKATP) channels, but not through pathways involving adenosine, protein kinase C, tyrosine kinase, or p38 mitogen-activated protein kinase. Isoflurane may directly activate mitoKATP channels.
This article has been cited by other articles:
![]() |
S. Lorsomradee, S. Cromheecke, S. Lorsomradee, and S. G De Hert Cardioprotection with Volatile Anesthetics in Cardiac Surgery Asian Cardiovasc Thorac Ann, June 1, 2008; 16(3): 256 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Riess, A. D. Costa, R. Carlson Jr, K. D. Garlid, A. Heinen, and D. F. Stowe Differential Increase of Mitochondrial Matrix Volume by Sevoflurane in Isolated Cardiac Mitochondria Anesth. Analg., April 1, 2008; 106(4): 1049 - 1055. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Symons and P. S. Myles Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis Br. J. Anaesth., August 1, 2006; 97(2): 127 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. M. de Klaver, G. S. Weingart, T. G. Obrig, and G. F. Rich Local anesthetic-induced protection against lipopolysaccharide-induced injury in endothelial cells: the role of mitochondrial adenosine triphosphate-sensitive potassium channels. Anesth. Analg., April 1, 2006; 102(4): 1108 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kohro, Q. H. Hogan, D. C. Warltier, and Z. J. Bosnjak Protein Kinase C Inhibitors Produce Mitochondrial Flavoprotein Oxidation in Cardiac Myocytes Anesth. Analg., November 1, 2004; 99(5): 1316 - 1322. [Abstract] [Full Text] [PDF] |
||||
|